MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)
MeiraGTx Holdings→botaretigene sparoparvovec (bota-vec)
Apr 16, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Tracking 1 M&A deal by MeiraGTx Holdings.
MeiraGTx Holdings→botaretigene sparoparvovec (bota-vec)
Apr 16, 2026